Trial Outcomes & Findings for Cerebral Oximetry and Neurological Outcomes in Aortic Arch Surgery Patients (NCT NCT01149148)

NCT ID: NCT01149148

Last Updated: 2015-04-28

Results Overview

The Mini-Mental State Examination (MMSE) or Folstein test is a brief 30-point questionnaire test that is used to screen for cognitive impairment. It is also used to estimate the severity of cognitive impairment at a specific time and to follow the course of cognitive changes in an individual over time, thus making it an effective way to document an individual's response to treatment. MMSE = Mini Mental State Exam - measures general orientation and mental status. Scores on a scale range from 0 - 30. Scores 23 and below are indicative of problems.

Recruitment status

COMPLETED

Study phase

PHASE3

Target enrollment

25 participants

Primary outcome timeframe

Baseline

Results posted on

2015-04-28

Participant Flow

Recruitment period: 11-2009 to 9-2011

Participant milestones

Participant milestones
Measure
Intervention INVOS Cerebral Oximetry Monitoring
\> 20% drop rSO2 from baseline or declines in rSO2 \< 50%
Standard of Care
Blinded cerebral oximetry monitoring with no intervention in surgical procedures and anesthesia without deviation from standard of care.
Overall Study
STARTED
12
13
Overall Study
COMPLETED
10
11
Overall Study
NOT COMPLETED
2
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Intervention INVOS Cerebral Oximetry Monitoring
\> 20% drop rSO2 from baseline or declines in rSO2 \< 50%
Standard of Care
Blinded cerebral oximetry monitoring with no intervention in surgical procedures and anesthesia without deviation from standard of care.
Overall Study
Lost to Follow-up
1
2
Overall Study
Death
1
0

Baseline Characteristics

Cerebral Oximetry and Neurological Outcomes in Aortic Arch Surgery Patients

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Intervention INVOS Cerebral Oximetry Monitoring
n=12 Participants
\> 20% drop rSO2 from baseline or declines in rSO2 \< 50%
Standard of Care
n=13 Participants
Blinded cerebral oximetry monitoring with no intervention in surgical procedures and anesthesia without deviation from standard of care.
Total
n=25 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
10 Participants
n=5 Participants
6 Participants
n=7 Participants
16 Participants
n=5 Participants
Age, Categorical
>=65 years
2 Participants
n=5 Participants
7 Participants
n=7 Participants
9 Participants
n=5 Participants
Age, Continuous
60.5 years
STANDARD_DEVIATION 9.414689 • n=5 Participants
62.30769 years
STANDARD_DEVIATION 11.52088 • n=7 Participants
61.44 years
STANDARD_DEVIATION 10.3846 • n=5 Participants
Sex: Female, Male
Female
5 Participants
n=5 Participants
5 Participants
n=7 Participants
10 Participants
n=5 Participants
Sex: Female, Male
Male
7 Participants
n=5 Participants
8 Participants
n=7 Participants
15 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline

The Mini-Mental State Examination (MMSE) or Folstein test is a brief 30-point questionnaire test that is used to screen for cognitive impairment. It is also used to estimate the severity of cognitive impairment at a specific time and to follow the course of cognitive changes in an individual over time, thus making it an effective way to document an individual's response to treatment. MMSE = Mini Mental State Exam - measures general orientation and mental status. Scores on a scale range from 0 - 30. Scores 23 and below are indicative of problems.

Outcome measures

Outcome measures
Measure
Intervention INVOS Cerebral Oximetry Monitoring
n=12 Participants
\> 20% drop rSO2 from baseline or declines in rSO2 \< 50%
Standard of Care
n=13 Participants
Blinded cerebral oximetry monitoring with no intervention in surgical procedures and anesthesia without deviation from standard of care.
Mini Mental State Examination (MMSE)
27 scores on a scale
Standard Deviation 1.651
26.769 scores on a scale
Standard Deviation 2.048

PRIMARY outcome

Timeframe: 3 Months

Population: Not all participants completed 3 month follow up neurocognitive testing.

The Mini-Mental State Examination (MMSE) or Folstein test is a brief 30-point questionnaire test that is used to screen for cognitive impairment. It is also used to estimate the severity of cognitive impairment at a specific time and to follow the course of cognitive changes in an individual over time, thus making it an effective way to document an individual's response to treatment. MMSE = Mini Mental State Exam - measures general orientation and mental status. Scores on a scale range from 0 - 30. Scores 23 and below are indicative of problems.

Outcome measures

Outcome measures
Measure
Intervention INVOS Cerebral Oximetry Monitoring
n=9 Participants
\> 20% drop rSO2 from baseline or declines in rSO2 \< 50%
Standard of Care
n=9 Participants
Blinded cerebral oximetry monitoring with no intervention in surgical procedures and anesthesia without deviation from standard of care.
Mini Mental State Examination (MMSE)
27.667 Scores on a scale
Standard Deviation 2.121
27 Scores on a scale
Standard Deviation 2.236

Adverse Events

Intervention INVOS Cerebral Oximetry Monitoring

Serious events: 1 serious events
Other events: 0 other events
Deaths: 0 deaths

Standard of Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Intervention INVOS Cerebral Oximetry Monitoring
n=12 participants at risk
\> 20% drop rSO2 from baseline or declines in rSO2 \< 50%
Standard of Care
n=13 participants at risk
Blinded cerebral oximetry monitoring with no intervention in surgical procedures and anesthesia without deviation from standard of care.
Cardiac disorders
Death
8.3%
1/12
0.00%
0/13

Other adverse events

Adverse event data not reported

Additional Information

Dr. Wei C. Lau

UmichiganHS

Phone: 734 9369479

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place